Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Nitin Ujjaliya"'
Publikováno v:
Indian Journal of Ayurveda and Integrative Medicine KLEU, Vol 3, Iss 1, Pp 12-20 (2022)
Thrombosis is one of the major causes of morbidity and mortality in a wide range of cardiovascular disorders (CVDs). CVDs are listed among top ten killer diseases. Antithrombotic drugs reduce the incidence of cardiovascular events about 20%–25% in
Externí odkaz:
https://doaj.org/article/09c9db17f5b54e02902564dd2282a4aa
A RETROSPECTIVE ANALYSIS OF EFFECT OF AROGYA KASHAYAM IN CONTACT CASES OF COVID-19 IN MADHYA PRADESH
Autor:
Umesh Shukla, Nitin Ujjaliya
Herbal compounds have been reported to be effective in SARS CoV-1 and other similar infections like H1N1 and Swine flu. To evaluate retrospectively the preventive role of intervention of Arogya Kashayam in Covid-19 contact cases at notified quarantin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::96389703d1b84f447b2163fd31894187
https://doi.org/10.31219/osf.io/en259
https://doi.org/10.31219/osf.io/en259
Autor:
Umesh Shukla, Nitin Ujjaliya
Introduction: The characteristic clinical features of Covid-19 disease range between asymptomatic to mild-moderate symptoms. Studies suggest that a large population (80%) presents its asymptomatic or milder form. Remaining 20 percent, owing to severi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b5c78b0f7fe89af4ab0d69eb111a7f11
https://doi.org/10.31219/osf.io/au3ct
https://doi.org/10.31219/osf.io/au3ct
Autor:
Umesh Shukla, Nitin Ujjaliya, Pankaj Gupta, Vivek Khare, Babita Yadav, Amit Kumar Rai, Hetalben Amin, Rakesh Rana, Arunabh Tripathi, Bhagwan S Sharma, Shruti Khanduri, Bhogavalli Chandrasekhararao, N. Srikanth, Kartar Singh Dhiman
Background: Currently, there is no approved treatment for the management of COVID-19 pandemic. Drug repurposing of existing medications could be a possible way to find out a novel therapeutic entity to combat the COVID-19.Objectives: To determine the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aee5e2e2c4826e56c76330f7293afaaf
https://doi.org/10.31219/osf.io/c8f9h
https://doi.org/10.31219/osf.io/c8f9h
Autor:
Umesh, Shukla, Nitin, Ujjaliya, Pankaj, Gupta, Vivek, Khare, Babita, Yadav, Amit Kumar, Rai, Hetalben, Amin, Rakesh, Rana, Arunabh, Tripathi, Shruti, Khanduri, Bhagwan Sahay, Sharma, Bhogavalli, Chandrasekhararao, Narayanam, Srikanth, Kartar Singh, Dhiman
Publikováno v:
Ayu. 41(3)
Currently, there is no approved treatment for the management of coronavirus disease (COVID-19). Drug repurposing of existing medications could be a possible way to find out a novel therapeutic entity to combat the COVID-19.To determine the clinical e
Publikováno v:
Ayu
Introduction: Coronavirus disease (COVID-19) is a newly identified strain of corona virus that causes illness ranging from the clinical features similar to the common cold to a fatal condition due to severe respiratory failure. According to the WHO,
Publikováno v:
AYUHOM. 9:19
Publikováno v:
INDIAN JOURNAL OF AYURVEDA & INTEGRATIVE MEDICINE KLEU. 3:12
Autor:
AmitKumar Rai, Umesh Shukla, Nitin Ujjaliya, Pankaj Gupta, Vivek Khare, Babita Yadav, Hetalben Amin, Rakesh Rana, Arunabh Tripathi, Shruti Khanduri, BhagwanSahay Sharma, Bhogavalli Chandrasekhararao, Narayanam Srikanth, KartarSingh Dhiman
Publikováno v:
AYU (An international quarterly journal of research in Ayurveda). 41:188
Publikováno v:
AYU (An international quarterly journal of research in Ayurveda). 40:209
Introduction: Coronavirus disease (COVID-19) is a newly identified strain of corona virus that causes illness ranging from the clinical features similar to the common cold to a fatal condition due to severe respiratory failure. According to the WHO,